Skip to content

Telephone Contact Between Hospital and General Practitioner About Medication Review for Older Patients

Can Telephone Contact After Discharge Between Geriatrician, Clinical Pharmacist and General Practitioner About Medication Review in Hospital Improve the Medication in Older Patients? A Feasibility Study.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03369652
Enrollment
232
Registered
2017-12-12
Start date
2017-11-24
Completion date
2018-11-30
Last updated
2019-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cross-sectional Communication, Medication Review, Older Patients

Brief summary

In this trial, the feasibility of cooperation between clinical pharmacists and physicians by conducting a telephone follow-up conversation between the hospital geriatrician, the general practitioner and the clinical pharmacist is evaluated. During hospital stay the clinical pharmacist and the geriatrician will review older patients' medication and discuss the future treatment with the general practitioner after discharge by telephone or medico-technology. The first part of the feasibility study will be a qualitative baseline measure of characteristics of the participants and work flow. The second part will be a pilot randomized controlled study where participants will be allocated to either usual care or medication review and follow up contact

Interventions

BEHAVIORALMedication review

Conducted by the pharmacist and discussed with hospital physician

Sponsors

Odense University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

\* 5 drugs or more

Exclusion criteria

* Terminal illness * Not able to speak and understand Danish

Design outcomes

Primary

MeasureTime frameDescription
Changes in number of medicationsAt admission and at dischargeIncrease or decrease in number of medications from admission to discharge
Parts of the intervention completedDay 1 after dischargeIn the intervention Group only, it is measured, how many of the elements of the intervention the patient actually have received
Changes in the Electronic Medication Profile (FMK)14 days after dischargeHow many changes have been Applied to the Electronic Medication Profile

Secondary

MeasureTime frameDescription
Number of visits at general practitionerwithin 30 days after dischargeData from registers
Health care professionals satisfaction3 months after implementationMeasured by a questionnaire
Changes in patient-experienced quality of lifeAt admission and 14 days after dischargeMeasured by telephone interview using the 5-item questionnaire EQ-5D, where each question can be answered on a 5-point Likert Scale ranging from very high degree of problems to very low degree of problems
Patient satisfaction with the discharge14 days after dischargeMeasured by telephone interview
Number of readmissionswithin 30 days after dischargeData from registers
Number of emergency visitswithin 30 days after dischargeData from registers

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026